Nutritional and Inflammatory Status of Hemodialysis Patients in Relation to Their Body Mass Index

Journal of Renal Nutrition

Volumn 19, Issue 3, 2009, Pages 238-247

  Beberashvili, Ilia ^a   Sinuani, Inna ^a   Azar, Ada ^a   Yasur, Hila ^a   Feldman, Leonid ^a   Efrati, Shai ^a   Averbukh, Zhan ^a   Weissgarten, Joshua ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; BIOLOGICAL MARKER; CREATININE; CYTOKINE; INTERLEUKIN DERIVATIVE; LEPTIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH STATUS; HUMAN; IMPEDANCE; INFLAMMATION; ISRAEL; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NUTRITIONAL STATUS; RENAL REPLACEMENT THERAPY;

AGED; ALBUMINS; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; CYTOKINES; ELECTRIC IMPEDANCE; FEMALE; HEALTH STATUS; HUMANS; INFLAMMATION; INTERLEUKINS; ISRAEL; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RENAL DIALYSIS; TRANSFERRIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64849114699     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.11.007     Document Type: Article

References (42)

1. Salahudeen A.K. Obesity and survival on dialysis. Am J Kidney Dis 41 (2003) 925-932
2. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
3. Kalantar-Zadeh K., Kopple J.D., Kilpatrick R.D., et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 (2005) 489-500
4. Warnberg J., Nova E., Moreno L.A., et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 84 (2006) 505-512
5. Park H.S., Park J.Y., and Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69 (2006) 29-35
6. De Vinuesa S.G., Goicoechea M., Kanter J., et al. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade. J Am Soc Nephrol 17 Suppl (2006) S206-S212
7. Bologa R.M., Levine D.M., Parker T.S., et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 (1998) 107-114
8. Stenvinkel P., Barany P., Heimburger O., et al. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?. Kidney Int 80 Suppl (2002) S103-S108
9. Rao M., Guo D., Perianayagam M.C., et al. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 45 (2005) 324-333
10. Zoccali C., Tripepi G., and Mallamaci F. Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?. J Am Soc Nephrol 17 Suppl (2006) S169-S173
11. Heimburger O., Lonnqvist F., Danielsson A., et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8 (1997) 1423-1430
12. Merabet E., Dagogo-Jack S., Coyne D.W., et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82 (1997) 847-850
13. Nordfors L., Lonnqvist F., Heimburger O., Danielsson A., Schalling M., and Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 54 (1998) 1267-1275
14. Don B.R., Rosales L.M., Levine N.W., Mitch W., and Kaysen G.A. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 59 (2001) 1114-1120
15. Ottonello L., Gnerre P., Bertolotto M., et al. Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol 15 (2004) 2366-2372
16. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6 Suppl (1998) S51-S20
17. Chertow G.M., Lowrie E.G., Wilmore D.W., et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol 6 (1995) 75-81
18. Chertow G.M., Lazarus J.M., Lew N.L., et al. Bioimpedance norms for the hemodialysis population. Kidney Int 52 (1997) 1617-1621
19. Kopple J.D., Zhu X., Lew N.L., and Lowrie E.G. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56 (1999) 1136-1148
20. Johansen K.L., Young B., Kaysen G.A., and Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80 (1999) 324-332
21. Fleischmann E., Teal N., Dudley J., et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55 (1999) 1560-1567
22. Salahudeen A.K., Fleischmann E.H., and Bower J.D. Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis. Kidney Int 56 (1999) 2254-2259
23. Pifer T.B., McCullough K.P., Port F.K., et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 62 (2002) 2238-2245
24. Ohkawa S., Odamaki M., Ikegaya N., et al. Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients. Nephrol Dial Transplant 20 (2005) 945-951
25. Nelson E.E., Hong C.D., Pesce A.L., et al. Anthropometric norms for the dialysis population. Am J Kidney Dis 16 (1990) 32-37
26. Cano N.J., Roth H., Aparicio M., et al. French Study Group for Nutrition in Dialysis (FSG-ND). Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int 62 (2002) 593-601
27. Maggiore Q., Nigrelli S., Ciccarelli C., Grimaldi C., Rossi G.A., and Michelassi C. Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 50 (1996) 2103-2108
28. Chertow G.M., Jacobs D.O., Lazarus J., et al. Phase angle predicts survival in hemodialysis patients. J Ren Nutr 4 (1997) 204-207
29. Beddhu S., Cheung A.K., Larive B., et al. Hemodialysis (HEMO) Study Group. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr 17 (2007) 372-380
30. Kahraman S., Yilmaz R., Akinci D., et al. U-shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr 15 (2005) 377-386
31. Kimmel P.L., Chawla L.S., Amarasinghe A., et al. Anthropometric measures, cytokines and survival in haemodialysis patients. Nephrol Dial Transplant 18 (2003) 326-332
32. Panichi V., Migliori M., De Pietro S., et al. Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif 18 (2000) 30-36
33. Kaizu Y., Kimura M., Yoneyama T., Miyaji K., Hibi I., and Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31 (1998) 93-100
34. Axelsson J., Qureshi A.R., Suliman M.E., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
35. Heimburger O., Wang T., Lonnqvist F., et al. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Nephrol Dial Transplant 14 (1999) 723-727
36. Coyne D.W., Dagogo-Jack S., Klein S., et al. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients. Am J Kidney Dis 32 (1998) 1031-1035
37. Yannakoulia M., Yiannakouris N., Bluher S., et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003) 1730-1736
38. Johansen K.L., Mulligan K., Tal V., and Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 9 (1998) 1080-1084
39. Pecoits-Filho R., Nordfors L., Heimburger O., et al. Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest 32 (2002) 811-817
40. Koo J.R., Pak K.Y., Kim K.H., et al. The relationship between plasma leptin and nutritional status in chronic hemodialysis patients. J Korean Med Sci 14 (1999) 546-551
41. Rammohan M., Kalantar-Zadeh K., Liang A., and Ghossein C. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 15 (2005) 345-355
42. Sinha M.K., Opentanova I., Ohannesian J.P., et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98 (1997) 1277-1282